12:00 AM
Sep 22, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Nucleosomics cancer detection test: Pilot trial start

This quarter, ValiRx will begin a pilot trial to use its Nucleosomics cancer detection test to evaluate 20-30 proven malignancy samples and an equal number...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >